High levels of p30 expression and/or the absence of p42, which is observed in CEBPA-mutated AML, might allow binding of p30 to genomic regions that harbor low-affinity C/EBPα motifs, thereby changing global C/EBPα-dependent gene expression. This evidence concerns the gene CEBPA and acute myeloid leukemia.